| dc.relation.references | ALEXANDRINO-DE-OLIVEIRA, P. et al. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Memórias do Instituto Oswaldo Cruz, v. 105, n. 5, p. 692–697, ago. 2010.
ANDERS, S.; PYL, P. T.; HUBER, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics, v. 31, n. 2, p. 166–169, 15 jan. 2015.
BLACKWELL, J. M.; FAKIOLA, M.; SINGH, O. P. Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, v. 10, 25 nov. 2020.
BRASIL. Manual de Vigilância e Controle da Leishmaniose Visceral. 1a ed. Brasília-DF: Ministério da Saúde, 2014. v. I
BRASIL. Situação Epidemiológica da Leishmaniose Visceral. Disponível em: <https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/l/leishmaniose-visceral/situacao-epidemiologica-da-leishmaniose-visceral>. Acesso em: 30 ago. 2022.
BUCCITELLI, C.; SELBACH, M. mRNAs, proteins and the emerging principles of gene expression control. Nature Reviews Genetics, v. 21, n. 10, p. 630–644, 24 out. 2020.
BURZA, S. et al. Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. PLoS Neglected Tropical Diseases, v. 8, n. 1, p. e2536, 2 jan. 2014.
BURZA, S.; CROFT, S. L.; BOELAERT, M. Leishmaniasis. The LancetLancet Publishing Group, , 15 set. 2018.
CALDAS, A. et al. Balance of IL-10 and interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis. BMC Infectious Diseases, v. 5, n. 1, p. 1–9, 19 dez. 2005.
CAMPOS, M. A. G. et al. Is splenectomy an option for multiple relapses in a child with visceral leishmaniasis? A case report. Revista da Sociedade Brasileira de Medicina Tropical, v. 54, 2021.
CARRIÓN, J. et al. Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunology, v. 28, n. 5, p. 173–183, 10 maio 2006.
CESTA, M. F. Normal Structure, Function, and Histology of the Spleen. Toxicologic Pathology, v. 34, n. 5, p. 455–465, 25 ago. 2006.
CHADBURN, A. The spleen: Anatomy and anatomical function. Seminars in Hematology, v. 37, p. 13–21, jan. 2000.
66
CHOWDHURY, B. P. et al. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania- infected BALB/c mice: critical role of IRF1. Pathogens and Disease, v. 73, n. 8, p. ftv063, nov. 2015.
COSTA, A. S. A. et al. Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Memórias do Instituto Oswaldo Cruz, v. 107, n. 6, p. 735–739, set. 2012.
COSTA, C. H. N. et al. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Revista da Sociedade Brasileira de Medicina Tropical, v. 43, n. 4, p. 386–392, 2010.
COSTA-MADEIRA, J. C. et al. T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis. Frontiers in Immunology, v. 13, 2 maio 2022.
CRETNEY, E. et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nature Immunology, v. 12, n. 4, p. 304–311, 6 abr. 2011.
DA SILVA SANTANA CRUZ, C. et al. Factors associated with human visceral leishmaniasis cases during urban epidemics in Brazil: A systematic review. ParasitologyCambridge University Press, , 1 maio 2021.
DA SILVA, T. A. M. et al. Prognostic factors associated with death from visceral leishmaniasis: a case-control study in Brazil. Transactions of The Royal Society of Tropical Medicine and Hygiene, v. 114, n. 5, p. 346–354, 7 maio 2020.
DAVID SIBLEY, L. Invasion and intracellular survival by protozoan parasites. Immunological Reviews, v. 240, n. 1, p. 72–91, mar. 2011.
DAYAKAR, A. et al. Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: Opportunities for novel diagnostics and immunotherapy. Frontiers in ImmunologyFrontiers Media S.A., , 2019.
DE ARAÚJO, V. E. M. et al. Early Clinical Manifestations Associated with Death from Visceral Leishmaniasis. PLoS Neglected Tropical Diseases, v. 6, n. 2, p. e1511, 7 fev. 2012.
DE MELO, C. V. B. et al. Splenic Transcriptional Responses in Severe Visceral Leishmaniasis: Impaired Leukocyte Chemotaxis and Cell Cycle Arrest. Frontiers in Immunology, v. 12, 5 nov. 2021.
DE SOUZA, T. L. et al. Pro-Cellular Exhaustion Markers are Associated with Splenic Microarchitecture Disorganization and Parasite Load in Dogs with Visceral Leishmaniasis. Scientific Reports, v. 9, n. 1, 1 dez. 2019.
DEAK, E. et al. Murine visceral leishmaniasis: IgM and polyclonal B‐cell activation lead to disease exacerbation. European Journal of Immunology, v. 40, n. 5, p. 1355–1368, 29 maio 2010.
67
DOBIN, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics, v. 29, n. 1, p. 15–21, 1 jan. 2013.
DOS SANTOS, P. L. et al. The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14. PLOS Neglected Tropical Diseases, v. 10, n. 1, p. e0004375, 27 jan. 2016.
DOS-SANTOS, W. L. et al. A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments. BMC Infectious Diseases, v. 14, n. 1, p. 491, 9 dez. 2014.
DUTRA, R. A. et al. Splenectomy in a patient with treatment-resistant visceral leishmaniasis: a case report. Revista da Sociedade Brasileira de Medicina Tropical, v. 45, n. 1, p. 130–131, fev. 2012.
ENDRIS, M. et al. Characteristics of bacterial sepsis among patients with visceral leishmaniasis. Asian Pacific Journal of Tropical Biomedicine, v. 4, n. 11, p. 871–875, nov. 2014.
FERNÁNDEZ-GUERRERO, M. L. et al. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Tropica, v. 90, n. 1, p. 11–16, mar. 2004.
FU, S.-H. et al. New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function. Journal of Biomedical Science, v. 24, n. 1, p. 49, 21 dez. 2017.
GARG, R. et al. Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha. PLoS neglected tropical diseases, v. 3, n. 5, 2009.
GHOSH, S. et al. Cytokines in the generation and function of regulatory T cell subsets in leishmaniasis. Cytokine, v. 147, p. 155266, nov. 2021.
GOODMAN, J. C. et al. Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Em: [s.l: s.n.]. p. 437–439.
GORSKI, S. et al. Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends. PLoS Neglected Tropical Diseases, v. 4, n. 6, p. e705, 8 jun. 2010.
GOTO, Y. et al. Short report: Elevation of serum B-cell activating factor levels during visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, v. 91, n. 5, p. 912–914, 2014.
GUEDESID, D. L. et al. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area. PLOS Neglected Tropical Diseases, v. 16, n. 6, p. e0010542, 1 jun. 2022.
68
HAILU, A. et al. ELEVATED PLASMA LEVELS OF INTERFERON (IFN)-, IFN-INDUCING CYTOKINES, AND IFN-INDUCIBLE CXC CHEMOKINES IN VISCERAL LEISHMANIASIS. [s.l: s.n.].
HENN, G. A. DE L. et al. Is Visceral Leishmaniasis the same in HIV-coinfected adults? Brazilian Journal of Infectious Diseases, v. 22, n. 2, p. 92–98, 1 mar. 2018.
HERMIDA, M. D. E. R. et al. Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis. Frontiers in cellular and infection microbiology, v. 8, n. November, p. 394, 2018.
KRAUS, M. D. Splenic histology and histopathology: An update. Seminars in Diagnostic Pathology, v. 20, n. 2, p. 84–93, 2003.
KUMAR, P. et al. Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis. Tropical Parasitology, v. 9, n. 1, p. 30, 1 jan. 2019.
KUROTAKI, D.; UEDE, T.; TAMURA, T. Functions and development of red pulp macrophages. Microbiology and Immunology, v. 59, n. 2, p. 55–62, fev. 2015.
LAURENTI, M. D. et al. Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector. Veterinary Parasitology, v. 196, n. 3–4, p. 296–300, set. 2013.
LEKIC, N. et al. Splenectomy for Visceral Leishmaniasis Out of an Endemic Region: A Case Report and Literature Review. Medicina, v. 58, n. 2, p. 184, 26 jan. 2022.
LEWIS, S. M.; WILLIAMS, A.; EISENBARTH, S. C. Structure and function of the immune system in the spleen. Science Immunology, v. 4, n. 33, 22 mar. 2019.
LIMA, I. S. et al. Severe clinical presentation of visceral leishmaniasis in naturally infected dogs with disruption of the splenic white pulp. PLoS ONE, v. 9, n. 2, 2014.
LINDOSO, J. A. L. et al. Visceral leishmaniasis and HIV coinfection: current perspectives. HIV/AIDS (Auckland, N.Z.), v. 10, p. 193, 2018.
LIU, R. et al. IL-17 Promotes Neutrophil-Mediated Immunity by Activating Microvascular Pericytes and Not Endothelium. The Journal of Immunology, v. 197, n. 6, p. 2400–2408, 15 set. 2016.
LONSDALE, J. et al. The Genotype-Tissue Expression (GTEx) project. Nature Genetics, v. 45, n. 6, p. 580–585, 29 jun. 2013.
MACLENNAN, I. C. M. Germinal Centers. Annual Review of Immunology, v. 12, n. 1, p. 117–139, abr. 1994.
MAIA, C. et al. Experimental Transmission of Leishmania infantum by Two Major Vectors: A Comparison between a Viscerotropic and a Dermotropic Strain. PLoS Neglected Tropical Diseases, v. 5, n. 6, p. e1181, 14 jun. 2011.
69
MAKSOUD, S. et al. Leishmania donovani and HIV co-infection in vitro: Identification and characterization of main molecular players. Acta Tropica, v. 228, p. 106248, 1 abr. 2022.
MANNAN, S. BIN et al. Prevalence and associated factors of asymptomatic leishmaniasis: a systematic review and meta-analysis. Parasitology International, v. 81, p. 102229, abr. 2021.
MARCO ANTÔNIO CARDOSO DE ALMEIDA. Caracterização histopatológica de casos fatais de Leishmaniose Visceral Humana: Estudo caso-controle de Necropsias. Tese (Doutorado)—Salvador: Universidade Federal da Bahia, 2019.
MARIE, J. C. et al. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. The Journal of Experimental Medicine, v. 201, n. 7, p. 1061–1067, 4 abr. 2005.
MAURYA, R. et al. Brief Definitive Report: Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite Immunology, v. 32, n. 7, p. 479–483, 19 mar. 2010.
MCKENZIE, C. V. et al. Splenomegaly: Pathophysiological bases and therapeutic options. The International Journal of Biochemistry & Cell Biology, v. 94, p. 40–43, jan. 2018.
MEBIUS, R. E.; KRAAL, G. Structure and function of the spleen. Nature Reviews Immunology, ago. 2005.
MEDRANO, F. J. et al. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clinical and Experimental Immunology, v. 114, n. 3, p. 403–407, 25 dez. 2001.
MELO, C. V. B. DE et al. Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis. Frontiers in Immunology, v. 11, n. April, p. 1–13, 2020.
MICHALICK, M. S. M.; RIBEIRO, R. R.; DA SILVA, S. M. Leishmaniose Visceral Americana. Em: NEVES, D. P. (Ed.). Parasitologia Humana. 13. ed. São Paulo: Atheneu, 2016. v. Ip. 69–90.
MONTES DE OCA, M.; ENGWERDA, C. R.; KAYE, P. M. Cytokines and splenic remodelling during Leishmania donovani infection. Cytokine: X, v. 2, n. 4, p. 100036, dez. 2020.
MOULIK, S. et al. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis. Parasite Immunology, v. 43, n. 1, p. e12783, 1 jan. 2021.
NAGELKERKE, S. Q. et al. Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors. Blood Advances, v. 2, n. 8, p. 941–953, 24 abr. 2018.
NASCIMENTO, E. T. et al. The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in Northeast Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 105, n. 5, p. 298–300, maio 2011.
70
NYLÉN, S. et al. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. Journal of Experimental Medicine, v. 204, n. 4, p. 805–817, 16 abr. 2007.
OHL, L. et al. Chemokines as organizers of primary and secondary lymphoid organs. Seminars in Immunology, v. 15, n. 5, p. 249–255, out. 2003.
OMACHI, S. et al. B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection. Biochemical and Biophysical Research Communications, v. 489, n. 4, p. 528–533, 2017.
PELISSARI, D. M. et al. Tratamento da Leishmaniose Visceral e Leishmaniose Tegumentar Americana no Brasil. Epidemiologia e Serviços de Saúde, v. 20, n. 1, p. 107–110, mar. 2011.
PEREZ, O. A. et al. CD169 + macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen. Science Immunology, v. 2, n. 16, 13 out. 2017.
PINTADO, V. et al. Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients: A Comparative Study. Medicine, v. 80, n. 1, 2001.
PRATA, A.; SILVA, L. A. Calazar. Em: COURA, J. R. (Ed.). Dinâmica das Doenças Infecciosas e Parasitárias. Rio de Janeiro: Guanabara Koogan, 2005. v. Ip. 713–732.
QUEIROZ, M. J. A.; ALVES, J. G. B.; CORREIA, J. B. Leishmaniose visceral: características clínico-epidemiológicas em crianças de área endêmica. Jornal de Pediatria, v. 80, n. 2, p. 141–146, abr. 2004.
RAI, A. K. et al. Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS ONE, v. 7, n. 2, 8 fev. 2012.
REBOUÇAS, A. et al. Leishmania-Induced Dendritic Cell Migration and Its Potential Contribution to Parasite Dissemination. Microorganisms, v. 9, n. 6, p. 1268, 11 jun. 2021.
REDMOND, H. P. et al. Surgical anatomy of the human spleen. British Journal of Surgery, v. 76, n. 2, p. 198–201, 7 dez. 2005.
REINALDO, L. G. C. et al. Splenectomy in Patients with Visceral Leishmaniasis Resistant to Conventional Therapy and Secondary Prophylaxis: A Retrospective Cohort. The American Journal of Tropical Medicine and Hygiene, v. 107, n. 2, p. 342–348, 17 ago. 2022.
REIS, L. L. DOS et al. Changes in the epidemiology of visceral leishmaniasis in Brazil from 2001 to 2014. Revista da Sociedade Brasileira de Medicina Tropical, v. 50, n. 5, set. 2017.
RIBEIRO-GOMES, F. L.; SACKS, D. The influence of early neutrophil-Leishmania interactions on the host immune response to infection. Frontiers in cellular and infection microbiology, 2012.
71
ROCHA, M. I. et al. Leishmania infantum Enhances Migration of Macrophages via a Phosphoinositide 3-Kinase Î-Dependent Pathway. ACS Infectious Diseases, v. 6, n. 7, p. 1643–1649, 10 jul. 2020.
ROGERS, M. E.; CHANCE, M. L.; BATES, P. A. The role of promastigote secretory gel in the origin and transmission of the infective stage of Leishmania mexicana by the sandfly Lutzomyia longipalpis. Parasitology, v. 124, n. 5, p. 495–507, 5 maio 2002.
ROMANO, A. et al. Interferon-γ-Producing CD4+ T Cells Drive Monocyte Activation in the Bone Marrow During Experimental Leishmania donovani Infection. Frontiers in Immunology, v. 12, 7 set. 2021.
SAMANT, M. et al. Role of Cytokines in Experimental and Human Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, v. 11, 18 fev. 2021a.
SAMANT, M. et al. Role of Cytokines in Experimental and Human Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, v. 11, 18 fev. 2021b.
SANTANA, C. C. et al. Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: A study on naturally infected dogs. Parasite Immunology, v. 30, n. 10, p. 515–524, 2008.
SAPORITO, L. et al. Visceral leishmaniasis: host–parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host. International Journal of Infectious Diseases, v. 17, n. 8, p. e572–e576, ago. 2013.
SHARMA, U.; SINGH, S. Insect vectors of Leishmania: distribution, physiology and their controlJ Vector Borne Dis. [s.l: s.n.].
SILVA, J. S. et al. Low CXCL13 expression, splenic lymphoid tissue atrophy and germinal center disruption in severe canine visceral leishmaniasis. PLoS ONE, 2012.
SILVA-BARRIOS, S.; CHARPENTIER, T.; STÄGER, S. The Deadly Dance of B Cells with Trypanosomatids. Trends in Parasitology, v. 34, n. 2, p. 155–171, 2018.
SILVA-O’HARE, J. et al. Disruption of splenic lymphoid tissue and plasmacytosis in canine visceral leishmaniasis: Changes in homing and survival of plasma cells. PLoS ONE, v. 11, n. 5, p. 1–17, 2016.
SINGH, N. et al. Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis. The Journal of Infectious Diseases, v. 218, n. 7, 24 ago. 2018.
SMEDLEY, D. et al. BioMart – biological queries made easy. BMC Genomics, v. 10, n. 1, p. 22, 14 dez. 2009.
SMELT, S. C. et al. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950), v. 158, n. 8, p. 3813–21, 15 abr. 1997.
72
STEINIGER, B.; RÜTTINGER, L.; BARTH, P. J. The Three-dimensional Structure of Human Splenic White Pulp Compartments. Journal of Histochemistry & Cytochemistry, v. 51, n. 5, p. 655–663, 26 maio 2003.
STEINIGER, B. S. Human spleen microanatomy: Why mice do not suffice. Immunology, v. 145, n. 3, p. 334–346, 2015.
STINGL, J. et al. Morphology and some biomechanical properties of human liver and spleen. Surgical and Radiologic Anatomy, v. 24, n. 5, p. 285–289, dez. 2002.
TAKELE, Y. et al. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV. Cell Reports Medicine, v. 3, n. 1, p. 100487, jan. 2022a.
TAKELE, Y. et al. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV. Cell Reports Medicine, v. 3, n. 1, p. 100487, 18 jan. 2022b.
VALLEJO, A. et al. High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, v. 34, n. 2, p. 267–275, 1 fev. 2015.
VARMA, N.; NASEEM, S. Hematologic Changes in Visceral Leishmaniasis/Kala Azar. Indian Journal of Hematology and Blood Transfusion 2010 26:3, v. 26, n. 3, p. 78–82, 30 set. 2010.
VERBOOGEN, D. R. J. et al. Interleukin-6 secretion is limited by self-signaling in endosomes. Journal of Molecular Cell Biology, v. 11, n. 2, p. 144–157, 1 fev. 2019.
VERESS, B. et al. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology, v. 33, n. 5, p. 605–10, nov. 1977.
VIANA, A. G. et al. Infection of Human Monocytes with Leishmania infantum Strains Induces a Downmodulated Response when Compared with Infection with Leishmania braziliensis. Frontiers in Immunology, v. 8, 8 jan. 2018.
VOLPEDO, G. et al. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development. Frontiers in ImmunologyFrontiers Media S.A., , 12 out. 2021.
VOLPIN, G. et al. Cytokine levels (IL-4, IL-6, IL-8 and TGFβ) as potential biomarkers of systemic inflammatory response in trauma patients. International Orthopaedics, v. 38, n. 6, p. 1303–1309, 2014.
WORLD HEALTH ORGANIZATION. Leishmaniasis. | pt_BR |